Moreover, TIMP2 could prevent the activation of tyrosine kinase receptors in tumor cells, including focal adhesion kinase38, AKT39 and epithelial growth factor receptor40, which play key roles in tumor migration and growth. Here, NTRK1 is linked to neoplasm.